Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Nycomed UK Ltd
Nycomed UK Ltd, 3 Globeside Business Park, Fieldhouse Lane, MARLOW, Buckinghamshire, SL7 1HZ, UK
Telephone: +44 (0)1628 646 400
Fax: +44 (0)1628 646 401
WWW: http://www.nycomed.com
Medical Information Direct Line: +44 (0) 800 633 5797
Medical Information e-mail: medinfo@nycomed.com
Medical Information Fax: +44 (0)1628 646 534

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 08/06/2011
PIL Alvesco 40, 80 and 160 Inhaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 08/06/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/10/2010 and displayed until 08/06/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/08/2010 and displayed until 25/10/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 17/02/2010 and displayed until 31/08/2010
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to Further Information section
  • Change to date of revision
  • Change to side-effects
  • Change to manufacturer contact details
Updated on 17/04/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 19/02/2009 and displayed until 17/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
Updated on 15/01/2009 and displayed until 19/02/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/02/2008 and displayed until 15/01/2009
Reasons for adding or updating:
  • Change of licence holder
  • Company name change or merger
  • Change to MA holder contact details
  • Change to date of revision
Updated on 13/07/2007 and displayed until 25/02/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 10/07/2006 and displayed until 13/07/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 05/05/2005 and displayed until 10/07/2006
Reasons for adding or updating:
  • Change to packaging
  • Change of contra-indications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 28/04/2005 and displayed until 05/05/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to storage instructions
  • Change to packaging
Updated on 15/02/2005 and displayed until 28/04/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  ciclesonide